HIGHLIGHTS
- who: Sara Silva and collaborators from the Faculty of Pharmacy, University of, Rua de Jorge Viterbo Ferreira, have published the research work: A Second Life for MAP, a Model Amphipathic Peptide, in the Journal: (JOURNAL)
- what: The studies showed that CPP can be used as a safe strategy to overcome drug penetration limitations and allows treatment of resistant cancer cell lines . This research demonstrated a new side of CPPs that can assume other cellular functions, rather than simply being a penetration delivery carrier, but which also presents some intrinsic activity and interaction with important proteins . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.